Company news
Avalo Therapeutics, Inc. news in 2021
Avalo Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
Avalo Therapeutics to Host Virtual Investor Day on January 6, 2022
December 15, 2021
Avalo Appoints Two New Independent Directors to Its Board
December 5, 2021
Avalo to Present at Two Upcoming Conferences
November 10, 2021
Avalo Reports Third Quarter 2021 Financial Results and Provides Business Updates
November 8, 2021
Avalo to Present at the Jefferies Virtual Next Generation IBD Therapeutics Summit
October 12, 2021
Avalo Therapeutics, Inc. Announces Closing of a $31.5 Million Public Offering of Common Stock, Including Proceeds from Exercise of Option to Purchase Additional Shares
September 16, 2021
Avalo Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
September 13, 2021
Avalo Therapeutics, Inc. Announces Pricing of $27.5 Million Public Offering of Common Stock
September 13, 2021
Decks in 2021
- Investor Presentation (September 2021)
Investor deck · 53 slides · Sep 9, 2021
- Corporate Update (August 2021)
Corporate update · 27 slides · August 2021
- Cerecor — Investor Presentation (July 2021)
Investor deck · 51 slides · Jul 26, 2021
- Cerecor — Technical Presentation (July 2021)
Technical · 27 slides · Jul 26, 2021
- Cerecor — Investor Presentation (March 2021)
Investor deck · 44 slides · Mar 17, 2021
- Cerecor — Investor Presentation (January 2021)
Investor deck · 43 slides · Jan 7, 2021
- Cerecor — Technical Presentation (January 2021)
Technical · 15 slides · Jan 5, 2021